However, in severe COVID-19 patients, the infection of alveolar epithelial cells by SARS-CoV-2 induces the production of chemokine CCL2, which attracts a large number of circulating monocytes and tissue-resident alveolar macrophages to the site of infection [58]. Here, CCL2 is linked to infection.